In Messimy, June 29, 2022

Press release

Boiron Laboratories, the world leader in homeopathy, has entrusted the distribution of its products in Switzerland to Verfora, the local leader in the sale of over-the-counter (OTC) medicines.

Boiron Laboratories and Verfora today announced the start of a distribution partnership in Switzerland. From October 1st, 2022, Boiron medicines will be marketed by the leader in the sale of over-the-counter (OTC) medicines in the country.

Thus, more than 800 products from the world leader in homeopathy will complete Verfora's existing therapeutic offer in the field of complementary medicine and reinforce its presence in homeopathy. The entire range is concerned, whether it be medicines with a common name without indication (Arnica montana 9 CH, Gelsemium sempervirens 15 CH...), reimbursed by the health insurance in Switzerland, or specialties (Oscillococcinum, Stodal, Camilia...).

Boiron and Verfora are convinced that this partnership will ensure the best use of the respective strengths of the two companies. Boiron will be able to benefit from Verfora's very good market coverage, particularly in German-speaking Switzerland, and Verfora from Boiron's extensive expertise in its field. In addition, the fact that a single supplier can offer a very wide range of products is a benefit for pharmacies and patients.

Both companies share the same core values based on respect, credibility, trust and devotion to the patient, and are committed to a long-term partnership.

Press contact:

Emeline Guiraud-Boisson - emeline.guiraud-boisson@boiron.fr- +33 (0)6 77 48 87 70

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Boiron SA published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 09:26:03 UTC.